Radicava
E561112
Radicava is a prescription medication containing edaravone, used to slow the progression of amyotrophic lateral sclerosis (ALS) in adults.
Observed surface forms (1)
| Surface form | Occurrences |
|---|---|
| Radicava ORS | 0 |
Statements (47)
| Predicate | Object |
|---|---|
| instanceOf |
brand name drug
ⓘ
oral suspension formulation of edaravone ⓘ prescription medication ⓘ |
| administrationSetting | healthcare facility ⓘ |
| approvedBy | U.S. Food and Drug Administration NERFINISHED ⓘ |
| ATCCode | N07XX11 ⓘ |
| commonAdverseEffect |
contusion
ⓘ
eczema ⓘ gait disturbance ⓘ headache ⓘ respiratory discomfort ⓘ |
| containsExcipient | sodium bisulfite ⓘ |
| contraindication | history of hypersensitivity to edaravone ⓘ |
| countryOfApproval | United States NERFINISHED ⓘ |
| dosageForm | solution for intravenous infusion ⓘ |
| firstApprovalYear | 2017 ⓘ |
| hasActiveIngredient |
edaravone
NERFINISHED
ⓘ
edaravone NERFINISHED ⓘ |
| hasAlternativeBrand | Radicava ORS NERFINISHED ⓘ |
| hasBoxedWarning | hypersensitivity reactions including anaphylaxis ⓘ |
| hasBrandName | Radicava NERFINISHED ⓘ |
| hasFormulation | intravenous formulation ⓘ |
| hasGenericName | edaravone NERFINISHED ⓘ |
| hasManufacturer |
Mitsubishi Tanabe Pharma
NERFINISHED
ⓘ
Mitsubishi Tanabe Pharma America, Inc. NERFINISHED ⓘ |
| indication | slow progression of functional decline in ALS ⓘ |
| indicationPopulation | ALS patients with mild to moderate functional impairment ⓘ |
| indicationType | disease-modifying treatment for ALS ⓘ |
| isNotIndicatedFor | pediatric patients ⓘ |
| legalStatus | prescription only ⓘ |
| mechanismOfAction | reduces oxidative stress by scavenging free radicals ⓘ |
| pharmacologicalClass | antioxidant ⓘ |
| pregnancyCategory | use only if potential benefit justifies potential risk ⓘ |
| regimenCharacteristic | cyclic dosing schedule ⓘ |
| requiresMonitoring |
respiratory status during infusion
ⓘ
signs of hypersensitivity ⓘ |
| routeOfAdministration |
intravenous infusion
ⓘ
oral ⓘ |
| storageCondition | store at controlled room temperature ⓘ |
| targetPopulation | adult patients ⓘ |
| therapeuticClass |
free radical scavenger
ⓘ
neuroprotective agent ⓘ |
| treats |
ALS in adults
ⓘ
amyotrophic lateral sclerosis ⓘ amyotrophic lateral sclerosis in adults ⓘ |
| warning |
risk of anaphylaxis
ⓘ
risk of hypersensitivity reactions ⓘ |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.
subject surface form:
Edaravone